1. Adriance, S.
(2014), “Fighting for the ‘right to try’ unapproved drugs: law and persuasion”,
The Yale Law Review Forum
, Vol. 124, pp. 148-157.
2. Altman, L.K.
(1982), “A new insulin given approval for use in the US”, The New York Times, October 30, available at: www.nytimes.com/1982/10/30/us/a-new-insulin-given-approval-for-use-in-us.html (accessed September 30, 2015).
3. Ballantine, C.
(1981), “Sulfanilamide disaster”, FDA Consumer Magazine, June, available at: www.fda.gov/aboutfda/whatwedo/history/productregulation/sulfanilamidedisaster/default.htm (accessed May 15, 2016).
4. Bateman-House, A.
,
Kimberly, L.
,
Redman, B.
,
Dubler, N.
and
Caplan, A.
(2015), “Right-to-try laws: hope, hype, and unintended consequences”,
Annals of Internal Medicine
, Vol. 163 No. 10, pp. 796-797.
5. Baumol, W.J.
(1990), “Entrepreneurship: productive, unproductive, and destructive”,
Journal of Political Economy
, Vol. 98 No. 5, pp. 893-921.